ARCHIVES

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

This article is from The Cancer Letter archive.

Vol. 10 No. 12 | March 23, 1984

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

IVAX And It’s Portfolio

December 22, 1994

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

August 2, 1985

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002